About 1,841,321 results (5,580 milliseconds)
Taletrectinib Signals Activity in ROS1-Positive Non–Small Cell Lung ...
https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L3RhbGV0cmVjdGluaWItc2lnbmFscy1hY3Rpdml0eS1pbi1yb3MxLXBvc2l0aXZlLW5vbi1zbWFsbC1jZWxsLWx1bmctY2FuY2Vy0gEA?oc=5 Sep 27, 2021 ... According to early clinical trial results, taletrectinib can induce responses in patients with ROS1-positive non–small cell lung cancer.
Consolidation Sugemalimab Prolongs PFS in Unresectable Stage III ...
https://news.google.com/__i/rss/rd/articles/CBMiaWh0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvY29uc29saWRhdGlvbi1zdWdlbWFsaW1hYi1wcm9sb25ncy1wZnMtaW4tdW5yZXNlY3RhYmxlLXN0YWdlLWlpaS1uc2NsY9IBAA?oc=5 Aug 7, 2022 ... Patients with stage III unresectable non–small cell lung cancer experienced a sustained progression-free survival benefit following ...
TTFields Plus SOC Meets Primary End Point in Stage IV NSCLC ...
https://news.google.com/__i/rss/rd/articles/CBMihQFodHRwczovL3d3dy5vbmNsaXZlLmNvbS92aWV3L3R0ZmllbGRzLXBsdXMtc29jLW1lZXRzLXByaW1hcnktZW5kLXBvaW50LWluLXN0YWdlLWl2LW5zY2xjLWFmdGVyLWZhaWx1cmUtb2YtcGxhdGludW0tYmFzZWQtY2hlbW90aGVyYXB50gEA?oc=5 Jan 5, 2023 ... The FDA granted fast track designation to IBI363 for squamous non–small cell lung cancer. Advertisement. US FDA. The FDA has granted ...
Immunotherapy for Small Cell Lung Cancer: Does It Work?
https://news.google.com/__i/rss/rd/articles/CBMiY2h0dHBzOi8vd3d3LmhlYWx0aGxpbmUuY29tL2hlYWx0aC9zbWFsbC1jZWxsLWx1bmctY2FuY2VyL2ltbXVub3RoZXJhcHktZm9yLXNtYWxsLWNlbGwtbHVuZy1jYW5jZXItMtIBAA?oc=5 Jun 1, 2021 ... Three primary classes of immunotherapy drugs are used to treat SCLC. Immune checkpoint inhibitors. Your immune system undergoes a process called ...
Durvalumab Combos Yield Better Reponses Than Monotherapy ...
https://news.google.com/__i/rss/rd/articles/CBMihQFodHRwczovL3d3dy5jYW5jZXJuZXR3b3JrLmNvbS92aWV3L2R1cnZhbHVtYWItY29tYm9zLXlpZWxkLWJldHRlci1yZXBvbnNlcy10aGFuLW1vbm90aGVyYXB5LXRyZWF0bWVudC1pbi11bnJlc2VjdGFibGUtc3RhZ2UtaWlpLW5zY2xj0gEA?oc=5 Nov 11, 2022 ... Patients with unresectable stage III non-small cell lung cancer ... Grade 3 or more treatment-emergent adverse effects (TEAEs) were seen in ...
Mohammadhadi Khorrami - Google Scholar
https://scholar.google.com/citations?user=8cRbAyQAAAAJ&hl=en Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic ...
Durvalumab Yields Clinically Meaningful OS Benefit but Misses the ...
https://news.google.com/__i/rss/rd/articles/CBMiiAFodHRwczovL3d3dy5jYW5jZXJuZXR3b3JrLmNvbS92aWV3L2R1cnZhbHVtYWIteWllbGRzLWNsaW5pY2FsbHktbWVhbmluZ2Z1bC1vcy1iZW5lZml0LWJ1dC1taXNzZXMtdGhlLW1hcmstaW4tcGQtbDEtaGlnaC1tZXRhc3RhdGljLW5zY2xj0gEA?oc=5 Dec 28, 2022 ... Reference. Update on PEARL phase III trial of Imfinzi monotherapy in stage IV non-small cell lung cancer. News release. AstraZeneca. December ...
Extensive-Stage Small Cell Lung Cancer: Gaps in Treatment
https://news.google.com/__i/rss/rd/articles/CBMiW2h0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvZXh0ZW5zaXZlLXN0YWdlLXNtYWxsLWNlbGwtbHVuZy1jYW5jZXItZ2Fwcy1pbi10cmVhdG1lbnTSAQA?oc=5 May 26, 2021 ... Kristie Kahl: What is the prognosis for patients at this stage? ... With non–small cell lung cancer, there's a list of things on the ...
Osimertinib Reaches High Achievement in EGFR+ NSCLC in the ...
https://news.google.com/__i/rss/rd/articles/CBMicWh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS9uZXdzL29zaW1lcnRpbmliLXJlYWNoZXMtaGlnaC1hY2hpZXZlbWVudC1pbi1lZ2ZyLW5zY2xjLWluLXRoZS1waGFzZS1paWktYWRhdXJhLXRyaWFs0gEA?oc=5 Apr 13, 2020 ... ... non–small cell lung cancer with complete tumor resection in the phase III ADAURA clinical trial.
ctDNA Reductions Associated With Improved Clinical Outcomes in ...
https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvY3RkbmEtcmVkdWN0aW9ucy1hc3NvY2lhdGVkLXdpdGgtaW1wcm92ZWQtY2xpbmljYWwtb3V0Y29tZXMtaW4tbnNjbGMtdHJlYXRlZC13aXRoLWlv0gEA?oc=5 Sep 16, 2022 ... Patients with non–small cell lung cancer who were treated with immune checkpoint inhibitors and experienced reductions in circulating tumor ...
Libtayo® (cemiplimab) Approved by the European Commission for ...
http://feedproxy.google.com/~r/organtransplantnews/~3/e9gyQsSY46M/url Jun 25, 2021 ... ... Phase 3 trial ... lung cancer called non-small cell lung cancer (NSCLC). Libtayo may be used as your first treatment when your lung cancer ...
LUIS GONZAGA PAZ-ARES RODRIGUEZ - Google Académico
https://scholar.google.com/citations?user=1ZAD0ScAAAAJ&hl=en The lancet oncology 13 (3), 239-246, 2012. 6213, 2012. Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer. SJ Antonia, A Villegas, D ...
Raymond Abratt - Google Scholar
https://scholar.google.com/citations?user=CgyklGEAAAAJ&hl=en Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study. RP Abratt, WR Bezwoda, G Falkson, L Goedhals, D Hacking, TA Rugg
Andrew M. Farach, MD - Google Scholar
https://scholar.google.com/citations?user=bLY17b8AAAAJ&hl=en International Journal of Radiation Oncology, Biology, Physics 78 (3), S202-S203, 2010. 12, 2010. Outcomes in elderly stage I non-small cell lung cancer in the ...
HARMONIC Evaluates Novel Combination in Growing Population of ...
https://news.google.com/__i/rss/rd/articles/CBMiggFodHRwczovL3d3dy5vbmNsaXZlLmNvbS92aWV3L2hhcm1vbmljLWV2YWx1YXRlcy1ub3ZlbC1jb21iaW5hdGlvbi1pbi1ncm93aW5nLXBvcHVsYXRpb24tb2YtbmV2ZXItc21va2Vycy13aXRoLWFkdmFuY2VkLWx1bmctY2FuY2Vy0gEA?oc=5 Nov 22, 2022 ... ... non–small cell lung cancer in the phase 2 HARMONIC study. Advertisement. LP-300 will be evaluated in never smokers with non–small cell lung ...
David Gandara - Google Scholar
https://scholar.google.com/citations?user=x1h5Z-EAAAAJ&hl=en Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non–small-cell lung cancer previously treated with platinum- ...
Jeffrey Bradley - Google Scholar
https://scholar.google.com/citations?user=4052TIgAAAAJ&hl=en Stereotactic body radiation therapy versus surgical resection for stage I non–small cell lung cancer. TD Crabtree, CE Denlinger, BF Meyers, I El Naqa, J Zoole, ...
Luigi Pasini - Google Scholar
https://scholar.google.com/citations?user=JUqEy7QAAAAJ&hl=en ... stage non-small cell lung cancer. A Verlicchi, M Canale, E Chiadini, P Cravero, M Urbini, K Andrikou, ... Life 13 (9), 1915, 2023. 3, 2023. Case report: the ...
cja haasbeek - Google Scholar
https://scholar.google.com/citations?user=4Tbg_CoAAAAJ&hl=en International Journal of Radiation Oncology* Biology* Physics 83 (1), 348-353, 2012. 425, 2012. Stage I–II non-small-cell lung cancer treated using either ...
George Rodrigues - Google Scholar
https://scholar.google.com/citations?user=F4g0iPAAAAAJ&hl=en Stage I–II non-small-cell lung cancer treated using either stereotactic ... phase 3, non … AC Tree, P Ostler, H van der Voet, W Chu, A Loblaw, D Ford ...